122 related articles for article (PubMed ID: 17609337)
1. MD-2 as the target of curcumin in the inhibition of response to LPS.
Gradisar H; Keber MM; Pristovsek P; Jerala R
J Leukoc Biol; 2007 Oct; 82(4):968-74. PubMed ID: 17609337
[TBL] [Abstract][Full Text] [Related]
2. Myeloid differentiation 2 as a therapeutic target of inflammatory disorders.
Park SH; Kim ND; Jung JK; Lee CK; Han SB; Kim Y
Pharmacol Ther; 2012 Mar; 133(3):291-8. PubMed ID: 22119168
[TBL] [Abstract][Full Text] [Related]
3. R-form LPS, the master key to the activation ofTLR4/MD-2-positive cells.
Huber M; Kalis C; Keck S; Jiang Z; Georgel P; Du X; Shamel L; Sovath S; Mudd S; Beutler B; Galanos C; Freudenberg MA
Eur J Immunol; 2006 Mar; 36(3):701-11. PubMed ID: 16506285
[TBL] [Abstract][Full Text] [Related]
4. MD-2 expression is not required for cell surface targeting of Toll-like receptor 4 (TLR4).
Visintin A; Halmen KA; Khan N; Monks BG; Golenbock DT; Lien E
J Leukoc Biol; 2006 Dec; 80(6):1584-92. PubMed ID: 16946018
[TBL] [Abstract][Full Text] [Related]
5. [TLR4/MD -2-dependent recognition of H. pylori LPS during gastric inflammation].
Ishihara S; Kinoshita Y
Nihon Rinsho; 2005 Nov; 63 Suppl 11():69-74. PubMed ID: 16363507
[No Abstract] [Full Text] [Related]
6. Soluble MD2 increases TLR4 levels on the epithelial cell surface.
Lauer S; Kunde YA; Apodaca TA; Goldstein B; Hong-Geller E
Cell Immunol; 2009; 255(1-2):8-16. PubMed ID: 18845299
[TBL] [Abstract][Full Text] [Related]
7. Studies of the TLR4-associated protein MD-2 using yeast-display and mutational analyses.
Mattis DM; Chervin AS; Ranoa DR; Kelley SL; Tapping RI; Kranz DM
Mol Immunol; 2015 Dec; 68(2 Pt A):203-12. PubMed ID: 26320630
[TBL] [Abstract][Full Text] [Related]
8. Toll-like receptor 4 agonists adsorbed to aluminium hydroxide adjuvant attenuate ovalbumin-specific allergic airway disease: role of MyD88 adaptor molecule and interleukin-12/interferon-gamma axis.
Bortolatto J; Borducchi E; Rodriguez D; Keller AC; Faquim-Mauro E; Bortoluci KR; Mucida D; Gomes E; Christ A; Schnyder-Candrian S; Schnyder B; Ryffel B; Russo M
Clin Exp Allergy; 2008 Oct; 38(10):1668-79. PubMed ID: 18631348
[TBL] [Abstract][Full Text] [Related]
9. Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran.
Kim HM; Park BS; Kim JI; Kim SE; Lee J; Oh SC; Enkhbayar P; Matsushima N; Lee H; Yoo OJ; Lee JO
Cell; 2007 Sep; 130(5):906-17. PubMed ID: 17803912
[TBL] [Abstract][Full Text] [Related]
10. Functional activity of MD-2 polymorphic variant is significantly different in soluble and TLR4-bound forms: decreased endotoxin binding by G56R MD-2 and its rescue by TLR4 ectodomain.
Vasl J; Prohinar P; Gioannini TL; Weiss JP; Jerala R
J Immunol; 2008 May; 180(9):6107-15. PubMed ID: 18424732
[TBL] [Abstract][Full Text] [Related]
11. Taxanes inhibit human TLR4 signaling by binding to MD-2.
Resman N; Gradisar H; Vasl J; Keber MM; Pristovsek P; Jerala R
FEBS Lett; 2008 Nov; 582(28):3929-34. PubMed ID: 18977229
[TBL] [Abstract][Full Text] [Related]
12. The lipopolysaccharide-recognition mechanism in cells expressing TLR4 and CD14 but lacking MD-2.
Ohnishi T; Muroi M; Tanamoto K
FEMS Immunol Med Microbiol; 2007 Oct; 51(1):84-91. PubMed ID: 17614960
[TBL] [Abstract][Full Text] [Related]
13. Evolution of lipopolysaccharide (LPS) recognition and signaling: fish TLR4 does not recognize LPS and negatively regulates NF-kappaB activation.
Sepulcre MP; Alcaraz-Pérez F; López-Muñoz A; Roca FJ; Meseguer J; Cayuela ML; Mulero V
J Immunol; 2009 Feb; 182(4):1836-45. PubMed ID: 19201835
[TBL] [Abstract][Full Text] [Related]
14. Bacterial lipopolysaccharide induces increased expression of toll-like receptor (TLR) 4 and downstream TLR signaling molecules in bovine mammary epithelial cells.
Ibeagha-Awemu EM; Lee JW; Ibeagha AE; Bannerman DD; Paape MJ; Zhao X
Vet Res; 2008; 39(2):11. PubMed ID: 18096120
[TBL] [Abstract][Full Text] [Related]
15. Toll-like receptor 4 initiates an innate immune response to lipopolysaccharide in human conjunctival epithelial cells.
Chung SH; Kweon MN; Lee HK; Choi SI; Yang JY; Kim EK
Exp Eye Res; 2009 Jan; 88(1):49-56. PubMed ID: 18951893
[TBL] [Abstract][Full Text] [Related]
16. TLR4 and MyD88 control protection and pulmonary granulocytic recruitment in a murine intranasal RSV immunization and challenge model.
Cyr SL; Angers I; Guillot L; Stoica-Popescu I; Lussier M; Qureshi S; Burt DS; Ward BJ
Vaccine; 2009 Jan; 27(3):421-30. PubMed ID: 19013492
[TBL] [Abstract][Full Text] [Related]
17. Hsp60-mediated T cell stimulation is independent of TLR4 and IL-12.
Osterloh A; Veit A; Gessner A; Fleischer B; Breloer M
Int Immunol; 2008 Mar; 20(3):433-43. PubMed ID: 18256040
[TBL] [Abstract][Full Text] [Related]
18. MD-2 determinants of nickel and cobalt-mediated activation of human TLR4.
Oblak A; Pohar J; Jerala R
PLoS One; 2015; 10(3):e0120583. PubMed ID: 25803856
[TBL] [Abstract][Full Text] [Related]
19. MD-2.
Visintin A; Iliev DB; Monks BG; Halmen KA; Golenbock DT
Immunobiology; 2006; 211(6-8):437-47. PubMed ID: 16920483
[TBL] [Abstract][Full Text] [Related]
20. The Role of Carbohydrates in the Lipopolysaccharide (LPS)/Toll-Like Receptor 4 (TLR4) Signalling.
Cochet F; Peri F
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29099761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
